Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:22 AM
Ignite Modification Date:
2025-12-25 @ 2:22 AM
NCT ID:
NCT00561834
Eligibility Criteria:
Inclusion Criteria:
* provide written informed consent
* 21 years of age or older
* new onset, within 14 days, of ischemia and vision loss
* Best Corrected Visual Acuity (BCVA) 20/40 or worse
Exclusion Criteria:
* pregnancy or lactation
* proliferative diabetic retinopathy,
* diabetic macular edema,
* uveitis,
* history of ocular trauma,
* severe glaucoma,
* age-related macular degeneration.
* prior or concomitant treatment of oral steroids within 30 days,
* participation in any studies of investigational drugs within 30 days,
* participation in a ranibizumab clinical trial or,
* prior treatment intravitreally or intravenously of Avastin or steroids.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
21 Years
Study:
NCT00561834
Study Brief:
Protocol Section:
NCT00561834